CRISPR THERAPEUTICS AG Other Comprehensive Income (Loss), Net of Tax
CRISPR THERAPEUTICS AG (CRSP) reported Other Comprehensive Income (Loss), Net of Tax of $8.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-04-29.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2019-04-29
- CRISPR THERAPEUTICS AG other comprehensive income (loss), net of tax for the quarter ending 2019-03-31 was $8.00K, a 33.33% decline year-over-year.
- CRISPR THERAPEUTICS AG other comprehensive income (loss), net of tax for the quarter ending 2018-03-31 was $12.00K.
- CRISPR THERAPEUTICS AG other comprehensive income (loss), net of tax for fiscal 2018 was -$22.00K, a 155.00% decline from fiscal 2017.
- CRISPR THERAPEUTICS AG other comprehensive income (loss), net of tax for fiscal 2017 was $40.00K.
- CRISPR THERAPEUTICS AG other comprehensive income (loss), net of tax for fiscal 2016 was -$18.00K.
- CRISPR THERAPEUTICS AG other comprehensive income (loss), net of tax for fiscal 2015 was -$6.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|
| 2019-03-31 | $8.00K 10-Q · filed 2019-04-29 | |
| 2018-12-31 | -$22.00K 10-K · filed 2019-02-25 | |
| 2018-03-31 | $12.00K 10-Q · filed 2019-04-29 | |
| 2017-12-31 | $40.00K 10-K · filed 2019-02-25 | |
| 2016-12-31 | -$18.00K 10-K · filed 2019-02-25 | |
| 2015-12-31 | -$6.00K 10-K · filed 2018-03-08 | |
| 2014-12-31 | -$2.00K 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |